Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.
about
The pharmacological landscape and therapeutic potential of serine hydrolasesInhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum.Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening.Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasisRecent patents of dipeptidyl peptidase IV inhibitors.Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia.Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro.Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques.Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometryFibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?Translational research on prolyl oligopeptidase inhibitors: the long road ahead.Target Fishing by Cross-Docking to Explain Polypharmacological Effects
P2860
Q26995817-B05182C6-CB3A-4B02-82CF-8987E22C8821Q35610164-75D58966-7971-4F9A-B533-78DFBC41859AQ36171916-1512F91A-FBE2-4418-AC41-FCF8EAB0CE85Q36406528-C7C19D2F-12B6-4B10-B706-C60486FF0344Q37186711-6E9D464B-41AF-4049-8E28-A362D2814B23Q37948110-F169B861-AB8B-41AF-8BA4-8CDDD69142D6Q38136309-3681B954-2DBE-47C2-8597-4482105033D6Q38668992-34571994-08C9-4D02-9DF6-B276ADA32889Q41544270-A41E73BB-FF31-48E9-9073-535BEF6E100CQ41996825-F024FC1B-4623-4830-8EDF-20BE94D7569EQ42242203-45CFF6B9-F77C-4DC8-949C-EE098534D401Q47922336-98E010B7-7940-47D4-A6E5-6D0FA1CFA99BQ49160469-FC5AEFC1-4E87-40E0-B5D4-2E3EECE0BA57Q57010613-E82294AA-FAF0-435C-8FF7-7D95C5229B81
P2860
Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@en
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@nl
type
label
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@en
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@nl
prefLabel
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@en
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@nl
P2860
P1476
Low molecular weight inhibitor ...... ds patented from 2003 to 2010.
@en
P2093
Teresa Tarragó
P2860
P304
P356
10.1517/13543776.2011.577416
P407
P577
2011-05-03T00:00:00Z